Condition: Malaria,Falciparum · Sponsor: University of Oxford
This is a Phase IIb randomised controlled trial of the safety, immunogenicity and efficacy of the blood-stage malaria vaccine candidates RH5.1 in Matrix-MTM and RH5.2-VLP in Matrix-MTM in infants aged 5-17 months in Burkina Faso
This description comes directly from the study's public registry record.
Jee-Sun Cho · +44 (0)1865 611418 · vaccinetrials@ndm.ox.ac.uk
Always discuss trial participation with your own doctor first.
| Institut de Recherche en Sciences de la Santé | Siglé, Boulkiemdé Province, Burkina Faso | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05790889